DK1186298T3 - Indretninger og fremgangsmåder til indgivelse af cannabis til patienter - Google Patents
Indretninger og fremgangsmåder til indgivelse af cannabis til patienterInfo
- Publication number
- DK1186298T3 DK1186298T3 DK01307509T DK01307509T DK1186298T3 DK 1186298 T3 DK1186298 T3 DK 1186298T3 DK 01307509 T DK01307509 T DK 01307509T DK 01307509 T DK01307509 T DK 01307509T DK 1186298 T3 DK1186298 T3 DK 1186298T3
- Authority
- DK
- Denmark
- Prior art keywords
- cannabis
- cavity
- chemical
- backing layer
- skin
- Prior art date
Links
- 240000004308 marijuana Species 0.000 title 1
- 241000218236 Cannabis Species 0.000 abstract 8
- 239000000126 substance Substances 0.000 abstract 7
- 239000010410 layer Substances 0.000 abstract 5
- 239000012790 adhesive layer Substances 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000002861 polymer material Substances 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/655,634 US6328992B1 (en) | 1997-03-03 | 2000-09-05 | Cannabinoid patch and method for cannabis transdermal delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1186298T3 true DK1186298T3 (da) | 2006-05-08 |
Family
ID=24629717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01307509T DK1186298T3 (da) | 2000-09-05 | 2001-09-04 | Indretninger og fremgangsmåder til indgivelse af cannabis til patienter |
Country Status (10)
Country | Link |
---|---|
US (1) | US6328992B1 (da) |
EP (1) | EP1186298B1 (da) |
AT (1) | ATE313320T1 (da) |
AU (1) | AU785275B2 (da) |
CA (1) | CA2356020C (da) |
CY (1) | CY1104990T1 (da) |
DE (1) | DE60116011T2 (da) |
DK (1) | DK1186298T3 (da) |
ES (1) | ES2253331T3 (da) |
PT (1) | PT1186298E (da) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8449908B2 (en) * | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
US20020111377A1 (en) * | 2000-12-22 | 2002-08-15 | Albany College Of Pharmacy | Transdermal delivery of cannabinoids |
US10004684B2 (en) * | 2001-02-14 | 2018-06-26 | Gw Pharma Limited | Pharmaceutical formulations |
GB0202385D0 (en) * | 2002-02-01 | 2002-03-20 | Gw Pharma Ltd | Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions |
WO2003063847A1 (en) * | 2002-02-01 | 2003-08-07 | Gw Pharma Limited | Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions |
WO2003066130A2 (en) * | 2002-02-07 | 2003-08-14 | Massachusetts Institute Of Technology | Transdermal drug delivery systems |
IL148244A0 (en) * | 2002-02-19 | 2002-09-12 | Yissum Res Dev Co | Anti-nausea and anti-vomiting activity of cannabidiol compounds |
AU2003240824B9 (en) * | 2002-05-31 | 2008-09-25 | University Of Mississippi | Transmucosal delivery of cannabinoids |
DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
US8906413B2 (en) * | 2003-05-12 | 2014-12-09 | Supernus Pharmaceuticals, Inc. | Drug formulations having reduced abuse potential |
WO2005000830A1 (en) * | 2003-06-24 | 2005-01-06 | Gw Pharma Limited | Pharmaceutical compositions comprising cabbinochreme type compounds |
CA2544900A1 (en) * | 2003-11-05 | 2005-05-19 | Unimed Pharmaceuticals, Inc. | Delta-9- the treatment of multiple sclerosis |
TWI369203B (en) | 2004-11-22 | 2012-08-01 | Euro Celtique Sa | Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol |
TWI366460B (en) | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
ZA200802767B (en) | 2005-09-29 | 2009-09-30 | Amr Technology Inc | Process for production of delta-9-tetrahydrocannabinol |
US20080008747A1 (en) * | 2006-07-07 | 2008-01-10 | Royds Robert B | Transdermal patch |
US20110150766A1 (en) * | 2006-07-07 | 2011-06-23 | Royds Robert B | Transdermal patch with fatal overdose protection |
US20100184848A1 (en) * | 2006-07-14 | 2010-07-22 | William Abraham Wine | Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
DE102007006244B4 (de) * | 2007-02-08 | 2012-03-15 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe |
JP5224163B2 (ja) * | 2007-07-24 | 2013-07-03 | コスメディ製薬株式会社 | 経皮吸収テープ製剤 |
CA2694325C (en) * | 2007-07-30 | 2015-09-22 | Alltranz Inc. | Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
US20090247619A1 (en) * | 2008-03-06 | 2009-10-01 | University Of Kentucky | Cannabinoid-Containing Compositions and Methods for Their Use |
US20090259176A1 (en) * | 2008-04-09 | 2009-10-15 | Los Gatos Research, Inc. | Transdermal patch system |
WO2010150245A1 (en) * | 2009-06-24 | 2010-12-29 | Tikun Olam Ltd. | Pharmaceutical and cosmeceutical compositions containing cannabis flower and seed extracts |
US20110038915A1 (en) * | 2009-08-14 | 2011-02-17 | Eduardo Jose Gonzalez | Chewing Gum Formula for Enhancing Psycho-Spirituality |
US9155713B2 (en) * | 2011-03-03 | 2015-10-13 | Mark Stephen Saia | Method and apparatus for alcohol administration and therapeutic treatments using same |
US8758826B2 (en) * | 2011-07-05 | 2014-06-24 | Wet Inc. | Cannabinoid receptor binding agents, compositions, and methods |
US10319475B1 (en) | 2014-06-13 | 2019-06-11 | Enigami Systems, Inc. | Method and apparatus for determining relationships between medications and symptoms |
CA2956919C (en) | 2014-07-21 | 2022-07-19 | Glia, Llc | Method for treating radiotherapy- and chemotherapy-associated cognitive or emotional impairment with cannabinoids |
US11707556B2 (en) | 2015-01-22 | 2023-07-25 | Alps South, LLC | Phase change material for thermal therapy and delivery of active ingredients |
US9375417B2 (en) | 2014-12-04 | 2016-06-28 | Mary's Medicinals LLC | Transdermal cannabinoid formulations |
US10028904B2 (en) | 2014-12-04 | 2018-07-24 | Wisconsin Alumni Research Foundation | Transdermal cannabinoid formulations |
US20160220593A1 (en) * | 2015-02-02 | 2016-08-04 | Axim Biotechnologies, Inc. | Cannabinoid and sugar alcohol complex, methods to make and use |
US9962340B2 (en) * | 2015-06-09 | 2018-05-08 | Life Tech Global, Llc | Device and method for the transdermal delivery of cannabidiol |
US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
US10272125B2 (en) * | 2015-09-14 | 2019-04-30 | Life Tech Global, Llc | Transdermal delivery of cannabidiol with other active moieties including cannabinoids |
LT6486B (lt) * | 2016-04-13 | 2018-01-10 | UAB "SatiMed" | Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui |
WO2018034793A1 (en) | 2016-07-21 | 2018-02-22 | Alps South, LLC | Phase change material for thermal therapy and delivery of active ingredients |
KR20190088076A (ko) | 2016-12-16 | 2019-07-25 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 유체 전달 장치 및 조립 방법 |
KR20190088073A (ko) * | 2016-12-16 | 2019-07-25 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 유체 전달 장치용 부착 밴드 및 그 이용 방법 |
US10569010B2 (en) | 2016-12-16 | 2020-02-25 | Sorrento Therapeutics, Inc. | Fluid delivery apparatus having a gas extraction device and method of use |
JP7008709B2 (ja) | 2016-12-16 | 2022-01-25 | ソレント・セラピューティクス・インコーポレイテッド | 制御アセンブリを有する流体送達装置及びその使用方法 |
KR102590629B1 (ko) | 2016-12-16 | 2023-10-19 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 유체 전달 장치용 어플리케이션 디바이스 및 그 이용 방법 |
KR20190088077A (ko) | 2016-12-16 | 2019-07-25 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 편두통 또는 군발두통을 치료하기에 적합한 투약 방법 |
WO2018125037A1 (en) * | 2016-12-27 | 2018-07-05 | John Garland | Medical marijuana patch |
GB2561262B (en) * | 2017-07-13 | 2019-03-20 | Dentmed Ltd | A targeted drug delivery pad |
WO2019016814A1 (en) | 2017-07-20 | 2019-01-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | PHARMACEUTICAL FILM COMPOSITIONS FOR THE ADMINISTRATION OF LIPOPHILIC COMPOUNDS IN AND / OR THROUGH THE SKIN |
CA3073799A1 (en) * | 2017-08-24 | 2019-02-28 | Zephyrious Health, Inc. | Transdermal formulations suitable for administration of natural products comprising plant flour and an adhesive |
SG11202003505RA (en) * | 2017-10-17 | 2020-07-29 | Remy Biosciences Inc | Improved delivery systems for moieties including cbd enhanced combinations, formulations and chimeras |
CA3108214A1 (en) | 2018-07-18 | 2020-01-23 | Glatt Gmbh | Extended release formulations of cannabinoids |
US10897925B2 (en) | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
US20200035118A1 (en) | 2018-07-27 | 2020-01-30 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
CA3113724A1 (en) * | 2018-09-28 | 2020-04-02 | Visceral Therapeutics Inc. | Pharmaceutically active cannabis-based compositions and methods of use for treating gastrointestinal conditions |
CA3077561A1 (en) * | 2018-10-15 | 2020-04-15 | Amnon VARDI | Slow release cannabinoids and products thereof |
WO2020236564A1 (en) * | 2019-05-17 | 2020-11-26 | Future Foam, Inc. | Cannabidiol infused foam element or surface |
US11090346B2 (en) | 2019-05-28 | 2021-08-17 | Inbold Inc. | Cannabinoid composition and method of sublingual, buccal and oral mucosa delivery |
US20230270803A1 (en) * | 2019-08-21 | 2023-08-31 | Pure GREEN PHARMACEUTICALS. INC. | Medical apparatus with cannabis sativa l. |
CA3156257A1 (en) * | 2019-10-03 | 2021-04-08 | Starton Therapeutics, Inc. | TRANSDERMAL DELIVERY OF DRONABINOL |
US12016829B2 (en) * | 2019-10-11 | 2024-06-25 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
US20210177740A1 (en) * | 2019-12-11 | 2021-06-17 | Joel Studin | Transpore delivery of cannabinoid and uses thereof |
WO2021138710A1 (en) * | 2020-01-09 | 2021-07-15 | Sg Ventures Pty Limited | Substrate for use in a transdermal patch or dressing |
US20210236687A1 (en) * | 2020-01-31 | 2021-08-05 | Pac-Dent, Inc. | Cannabinoid-based oral hemostatic compositions |
AU2021328741A1 (en) * | 2020-08-17 | 2023-02-02 | Pike Therapeutics, Inc. | Pharmaceutical compositions and methods for treating Parkinson's disease |
US20220087948A1 (en) * | 2020-09-18 | 2022-03-24 | Nanovibronix, Inc. | Transdermal patch of a portable ultrasound-generating system for improved delivery of therapeutic agents and associated methods of treatment |
WO2022118303A1 (en) * | 2020-12-03 | 2022-06-09 | Pike Therapeutics, Inc. | Transdermal pharmaceutical formulations comprising cbd or thc for the treatment of cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US302116A (en) * | 1884-07-15 | Jean baptist alois db winteb | ||
US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
US6113940A (en) * | 1997-03-03 | 2000-09-05 | Brooke; Lawrence L. | Cannabinoid patch and method for cannabis transdermal delivery |
-
2000
- 2000-09-05 US US09/655,634 patent/US6328992B1/en not_active Expired - Lifetime
-
2001
- 2001-08-27 CA CA002356020A patent/CA2356020C/en not_active Expired - Lifetime
- 2001-08-29 AU AU65540/01A patent/AU785275B2/en not_active Expired
- 2001-09-04 PT PT01307509T patent/PT1186298E/pt unknown
- 2001-09-04 EP EP01307509A patent/EP1186298B1/en not_active Expired - Lifetime
- 2001-09-04 ES ES01307509T patent/ES2253331T3/es not_active Expired - Lifetime
- 2001-09-04 AT AT01307509T patent/ATE313320T1/de active
- 2001-09-04 DK DK01307509T patent/DK1186298T3/da active
- 2001-09-04 DE DE60116011T patent/DE60116011T2/de not_active Expired - Lifetime
-
2006
- 2006-03-02 CY CY20061100291T patent/CY1104990T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1104990T1 (el) | 2009-11-04 |
US6328992B1 (en) | 2001-12-11 |
DE60116011D1 (de) | 2006-01-26 |
EP1186298A3 (en) | 2003-01-02 |
EP1186298B1 (en) | 2005-12-21 |
CA2356020C (en) | 2006-12-19 |
AU785275B2 (en) | 2006-12-14 |
ATE313320T1 (de) | 2006-01-15 |
AU6554001A (en) | 2002-03-07 |
ES2253331T3 (es) | 2006-06-01 |
PT1186298E (pt) | 2006-05-31 |
DE60116011T2 (de) | 2006-08-24 |
EP1186298A2 (en) | 2002-03-13 |
CA2356020A1 (en) | 2002-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1186298T3 (da) | Indretninger og fremgangsmåder til indgivelse af cannabis til patienter | |
AU2961802A (en) | Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system | |
DE50112720D1 (de) | Transdermales therapeutisches system mit hochdispersem siliziumdioxid | |
DK0716620T3 (da) | Reservoir,som kan imprægneres med en opløsning af aktivt stof, til en ionoforetisk anordning til transdermal indgivelse af medicin, og fremgangsmåde til fremstilling af et sådant reservoir | |
PT91327A (pt) | Emplastro de varias camadas | |
YU165789A (en) | Use of asymmetrical membranes in agents for active substances controlled releasing | |
DE69524436D1 (de) | Verbesserte transdermale vorrichtung mit verringerter delaminierung | |
DK0674913T3 (da) | Ikke-okklusivt klæbende plaster til påföring af medicament i huden | |
DK1524975T3 (da) | Forbedret, transdermalt tilförselssystem til indgivelse af rotigotin | |
ATE526038T1 (de) | Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle | |
JP2006525316A5 (da) | ||
DK722888A (da) | Plaster med aktivstof til kontrolleret administration af aktivstoffer til huden | |
WO2002078602A3 (en) | Transdermal delivery of pergolide | |
DK1251853T3 (da) | Transdermalt terapeutisk system til indgivelse af zaleplon | |
ATE416738T1 (de) | Schiene mit feuchtigkeitsundurchlässiger lage | |
DE20221247U1 (de) | Transdermal-Pflaster zum Verabreichen von Fentanyl |